» Articles » PMID: 37426425

When the Allergy Alarm Bells Toll: The Role of Toll-like Receptors in Allergic Diseases and Treatment

Overview
Specialty Biology
Date 2023 Jul 10
PMID 37426425
Authors
Affiliations
Soon will be listed here.
Abstract

Toll-like receptors of the human immune system are specialized pathogen detectors able to link innate and adaptive immune responses. TLR ligands include among others bacteria-, mycoplasma- or virus-derived compounds such as lipids, lipo- and glycoproteins and nucleic acids. Not only are genetic variations in TLR-related genes associated with the pathogenesis of allergic diseases, including asthma and allergic rhinitis, their expression also differs between allergic and non-allergic individuals. Due to a complex interplay of genes, environmental factors, and allergen sources the interpretation of TLRs involved in immunoglobulin E-mediated diseases remains challenging. Therefore, it is imperative to dissect the role of TLRs in allergies. In this review, we discuss i) the expression of TLRs in organs and cell types involved in the allergic immune response, ii) their involvement in modulating allergy-associated or -protective immune responses, and iii) how differential activation of TLRs by environmental factors, such as microbial, viral or air pollutant exposure, results in allergy development. However, we focus on iv) allergen sources interacting with TLRs, and v) how targeting TLRs could be employed in novel therapeutic strategies. Understanding the contributions of TLRs to allergy development allow the identification of knowledge gaps, provide guidance for ongoing research efforts, and built the foundation for future exploitation of TLRs in vaccine design.

Citing Articles

Integration of functional genomics and statistical fine-mapping systematically characterizes adult-onset and childhood-onset asthma genetic associations.

Zhong X, Mitchell R, Billstrand C, Thompson E, Sakabe N, Aneas I medRxiv. 2025; .

PMID: 40034789 PMC: 11875274. DOI: 10.1101/2025.02.11.25322088.


Continuous Treatment with IncobotulinumtoxinA Despite Presence of BoNT/A Neutralizing Antibodies: Immunological Hypothesis and a Case Report.

Martin M, Tay C, Siew T Toxins (Basel). 2024; 16(10).

PMID: 39453199 PMC: 11510976. DOI: 10.3390/toxins16100422.


PWAS Hub for exploring gene-based associations of common complex diseases.

Kelman G, Zucker R, Brandes N, Linial M Genome Res. 2024; 34(10):1674-1686.

PMID: 39406500 PMC: 11529988. DOI: 10.1101/gr.278916.123.


Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitization.

Jackson K, Buhl C, Miller S, Khalaf J, Ward J, Sands C Front Immunol. 2024; 15:1421758.

PMID: 39108263 PMC: 11300337. DOI: 10.3389/fimmu.2024.1421758.


TLR2 and TLR4 Are Expressed in Epiretinal Membranes: Possible Links with Vitreous Levels of Complement Fragments and DAMP-Related Proteins.

Dinice L, Esposito G, Cacciamani A, Balzamino B, Cosimi P, Cafiero C Int J Mol Sci. 2024; 25(14).

PMID: 39062973 PMC: 11276880. DOI: 10.3390/ijms25147732.


References
1.
Brugnolo F, Sampognaro S, Liotta F, Cosmi L, Annunziato F, Manuelli C . The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. J Allergy Clin Immunol. 2003; 111(2):380-8. DOI: 10.1067/mai.2003.102. View

2.
Umborowati M, Damayanti D, Anggraeni S, Endaryanto A, Surono I, Effendy I . The role of probiotics in the treatment of adult atopic dermatitis: a meta-analysis of randomized controlled trials. J Health Popul Nutr. 2022; 41(1):37. PMC: 9386980. DOI: 10.1186/s41043-022-00318-6. View

3.
Li X, Ampleford E, Howard T, Moore W, Torgerson D, Li H . Genome-wide association studies of asthma indicate opposite immunopathogenesis direction from autoimmune diseases. J Allergy Clin Immunol. 2012; 130(4):861-8.e7. PMC: 3579216. DOI: 10.1016/j.jaci.2012.04.041. View

4.
Deifl S, Kitzmuller C, Steinberger P, Himly M, Jahn-Schmid B, Fischer G . Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients. Allergy. 2014; 69(12):1602-9. PMC: 4245478. DOI: 10.1111/all.12501. View

5.
Ferreira M, Matheson M, Duffy D, Marks G, Hui J, Le Souef P . Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 2011; 378(9795):1006-14. PMC: 3517659. DOI: 10.1016/S0140-6736(11)60874-X. View